Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
6.22
-0.28 (-4.31%)
Sep 24, 2026, 4:00 PM EDT - Market closed
Entrada Therapeutics Market Cap
Entrada Therapeutics has a market cap or net worth of $224.27 million as of September 24, 2026. Its market cap has increased by 23.93% in one year.
Market Cap
224.27M
Enterprise Value
49.81M
1-Year Change
23.93%
Ranking
Category
Stock Price
$6.22
ChartMarket Cap Chart
Since the IPO on October 29, 2021, Entrada Therapeutics's market cap has decreased from $251.01M to $224.27M, a decrease of -10.65%. That is a compound annual growth rate of -2.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 224.27M | -39.16% |
| Dec 31, 2025 | 368.66M | -39.78% |
| Dec 31, 2024 | 612.16M | 21.70% |
| Dec 29, 2023 | 503.01M | 18.72% |
| Dec 30, 2022 | 423.70M | -20.71% |
| Dec 31, 2021 | 534.36M | 112.88% |
| Oct 29, 2021 | 251.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lineage Cell Therapeutics | 254.17M |
| Foghorn Therapeutics | 242.89M |
| Cue Biopharma | 235.80M |
| Cartesian Therapeutics | 235.69M |
| Compugen | 232.07M |
| Keros Therapeutics | 231.78M |
| Eledon Pharmaceuticals | 231.01M |
| Whitehawk Therapeutics | 228.04M |